How India is Securing the World's Pharmaceutical Supply Chain
The COVID-19 pandemic highlighted a major vulnerability in the global pharmaceutical supply chain: an over-reliance on a few key countries for Active Pharmaceutical Ingredients (APIs). Recognizing this risk, nations around the world have been seeking to diversify their sources, and India has emerged as a trusted partner. With its vast manufacturing capacity, skilled scientific workforce, and a proven track record of producing high-quality generics, India is well-positioned to strengthen the global supply chain. The Indian government has also played a crucial role through its Production Linked Incentive (PLI) schemes, which provide financial support to companies investing in the domestic manufacturing of key APIs and intermediates. These initiatives are not just about India's self-reliance; they are about building a more resilient and reliable global network that can better withstand future disruptions. This strategic effort is a major driver of the growth and importance of the INDIA API Market.